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Health/diseaseThe endogenous synthesis of lipids, which requires suitable dietary rawmaterials, is critical for the formation of
membrane bilayers. In eukaryotic cells, phospholipids are the predominant membrane lipids and consist of hy-
drophobic acyl chains attached to a hydrophilic head group. The relative balance between saturated, monounsat-
urated, and polyunsaturated acyl chains is required for the organization and normal function of membranes.
Virgin olive oil is the richest natural dietary source of the monounsaturated lipid oleic acid and is one of the
key components of the healthy Mediterranean diet. Virgin olive oil also contains a unique constellation of
many other lipophilic and amphipathic constituents whose health beneﬁts are still being discovered. The focus
of this review is the latest evidence regarding the impact of oleic acid and the minor constituents of virgin
olive oil on the arrangement and behavior of lipid bilayers. We highlight the relevance of these interactions to
the potential use of virgin olive oil in preserving the functional properties of membranes to maintain health
and inmodulating membrane functions that can be altered in several pathologies. This article is part of a Special
Issue entitled: Membrane Structure and Function: Relevance in the Cell's Physiology, Pathology and Therapy.
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Chemical structure and range of major fatty acids in virgin olive oil.
Fatty acid Regulationsa
(%)
16:0, palmitic acid 7.5–20.01. Introduction
Virgin olive oil plays a pivotal role as the main source of fat in the
Mediterranean diet, a diet that has traditionally been linked to longevity
in Mediterranean populations and is associated with a signiﬁcant
improvement in health status, as measured by reduced mortality from
several chronic diseases [1–8].
More than 90% of olive oil is formed in the mesocarp of the drupe
from the fruit of the olive tree (Olea europaea L.). Virgin olive oil (for
olive oil classiﬁcation anddeﬁnitions see Ref. [9]) is obtained exclusively
from fresh and healthy olives by physical procedures under low thermal
conditions (b27 °C) and is the only edible fat that can be consumed as a
natural fruit product with no additives or preservatives. Spain is by far
the largest producer of virgin olive oil in the world, accounting for ap-
proximately 50% (~1,600,000 tons) of total global production in 2012
[10]. More recently, due to the increasing recognition of the unique
health properties of virgin olive oil, interest in virgin olive oil production
has extended to countries outside the Mediterranean region, such as
western Africa, Argentina, Australia, Azerbaijan, Brazil, China, India,
Japan, Mexico, New Zealand, South Africa, and the USA.
The main bioactive constituents of virgin olive oil include monoun-
saturated oleic acid and a variety of compounds present in lower quanti-
ties (“minor constituents”) [3,4,9,11–15; and references within the
manuscript]. Almost all fatty acids (FAs) exist as a complex in the form
of triacylglycerol, an ester derived from glycerol and 3 FAs (saponiﬁable
fraction, N98%). The triacylglycerol content of virgin olive oil is responsi-
ble for its hydrophobicity. The minor constituents (unsaponiﬁable frac-
tion, up to 1.5%) contribute to the speciﬁc properties of virgin olive oil,
including its oxidative stability and unique ﬂavor, as well as its color
(the pigments in virgin olive oil include carotenoids and chlorophylls).
Cells can simultaneously acquire or import a spectrum of precursors
through endocytosis of circulating lipoproteins of endogenous or exog-
enous (dietary) origin, which affects the biogenesis and remodeling of
membranes. In this review, we will address the impact of the bioactive
constituents of virgin olive oil on the modulation of membrane compo-
sition and function in the context of health and disease, as well as the
potential therapeutic applications of these bioactive constituents.16:1n− 7, palmitoleic acid 0.3–3.5
18:0, stearic acid 0.5–5.0
18:1n− 9, oleic acid 55.0–83.0
18:2n− 6, linoleic acid 3.5–21.0
18:3n− 3, α-linolenic acid ≤1.0
MUFAs, monounsaturated fatty acids 53–87
SFAs, saturated fatty acids 8–26
PUFAs, polyunsaturated fatty acids 3–22
a International Olive Oil Council (www.internationaloliveoil.org).2. Virgin olive oil: major and minor bioactive constituents
2.1. Oleic acid
FAs are carboxylic acids and often contain a long, unbranched ali-
phatic chain. FAs are categorized as saturated (SFA), monounsaturated
(MUFA), and polyunsaturated (PUFA), based on their structural and
chemical properties. SFAs do not contain any double bonds or other
functional groups along the chain, which is fully saturated with hydro-
gen atoms. The principal dietary SFAs are palmitic (16:0) and stearic
(18:0) acids, which are composed of 16 and 18 carbon atoms, respec-
tively. MUFAs contain one pair of carbon atoms linked by a cis double
bond. Oleic acid (18:1n− 9), which contains 18 carbon atoms with a
double bond at the 9th carbon from the methyl end of the FA molecule,
is the major dietary MUFA and represents 55 to 83% of the total FAs in
virgin olive oil (Table 1). Carbon chains containing 2 or more cis double
bonds, with the ﬁrst double bond located between either the 3rd and
4th or the 6th and 7th carbon atoms from themethyl end of the FAmol-
ecule, belong to the n− 3 or n− 6, respectively, PUFA families. Thesefamilies cannot be synthesized by the human body (double bonds can
be introduced into all positions of the FA chain with the exception of
the n− 3 and n− 6 positions) and therefore must be obtained from
the diet as α-linolenic acid (18:3n− 3) and linoleic acid (18:2n− 6)
or their long-chain PUFA derivatives. Of these FAs, eicosapentaenoic
acid (20:5n − 3), docosahexaenoic acid (22:6n − 3), dihomo-γ-
linolenic acid (20:3n− 6), and arachidonic acid (20:4n− 6) are the
most metabolically signiﬁcant. The concentrations of SFAs (palmitic +
stearic acids) and PUFAs (α-linolenic + linoleic acids) in virgin olive
oil range from 8 to 25% and from 3 to 21% of the total FAs, respectively.
Some parameters, such as the area of production, altitude, climate, fruit
variety, and stage of maturity of the fruit can greatly affect the FA com-
position of virgin olive oil [16].
Oleic acid is the primary component of virgin olive oil (~83% oleic
acid in position sn− 2 of the triacylglycerols) and is also found in pea-
nut oil (~59% oleic acid in position sn− 2 of the triacylglycerols) and
canola oil (~37% oleic acid in position sn − 2 of the triacylglycerols).
However, stearoyl-CoA desaturase 1 (SCD1, similar to the mouse
orthologue mScd1), which is anchored in the endoplasmic reticulum
(ER) of hepatocytes and adipose tissue cells [17], plays a central role
in partitioning endogenous and exogenous (dietary) FAs into metabol-
ically active or inactive pools and is the rate-limiting enzyme for the bio-
synthesis of MUFAs (mainly oleic acid) from SFAs. SCD1 catalyzes the
insertion of a cis double bond into the 9th carbon atom of palmitic and
stearic acids. Oleic acid is a key component of triacylglycerols andmem-
brane lipids [18]. Importantly, oleic acid is the most common FA in na-
ture, as well as in our diet (generally, oleic acid supplies an amount of
calories equivalent or greater than the amount provided by SFAs and
Table 2
Mean values of major fatty acids in several human tissues.
Fatty acid Subcutaneous
adipose tissue
[ref. 19]
Skeletal
musclea
[ref. 20]
Skeletal
muscleb
[ref. 20]
Heartc
[ref. 21]
Aorta
[ref. 22]
Liver
[ref. 19]
Braind
[ref. 23]
Cerebrospinal
ﬂuid
[ref. 24]
Whole
blood
[ref. 24]
Erythrocytee
[ref. 25]
14:0, myristic acid 2 3 0.7 1 5 2 0.7 n.d. n.d. n.d.
16:0, palmitic acid 22 23 23 27 22 28 21 28 23 35
16:1n− 7, palmitoleic acid 6 5 0.6 0.8 n.d. 4 2 3 3 n.d.
18:0, stearic acid 3 6 18 6 8 8 21 19 9 11
18:1n− 9, oleic acid 50 51 15 12 31 35 17 25 21 18
18:2n− 6, linoleic acid 11 10 30 16 9 12 0.9 7 20 19
18:3n− 3, α-linolenic acid 1 0.8 0.3 0.2 8 0.9 n.d. 3 0.7 0.2
20:3n− 6, dihomo-γ-linolenic acid 0.3 0.2 1 0.8 n.d. 0.8 1 1 2 n.d.
20:4n− 6, arachidonic acid 0.6 0.3 10 16 3 4 9 3 8 5
20:5n− 3, eicosapentaenoic acid 0.1 n.d. 1 0.4 3 0.5 n.d. 2 2 1
22:6n− 3, docosahexaenoic acid 0.3 0.4 2 2 n.d. 3 15 1 4 2
n.d., not determined.
a Skeletal muscle triglycerides.
b Skeletal muscle phospholipids.
c Heart phosphatidylcholine.
d Frontal neocortex (similar mean values are found in temporal and parietal neocortex).
e Erythrocyte phosphatidylcholine.
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daily calories; less than 7% for high-risk individuals) and PUFA con-
sumption (b10%) have been recommended. By contrast, oleic acid
may provide up to 20–25% of total daily calories. In fact, oleic acid is
one of the most abundant FA in the human body (Table 2) [19–25].
2.2. Minor constituents
Like other fruits and vegetables, olives synthesize a variety of
compounds (N230 “minor constituents”) in response to stress condi-
tions including infection, wounds, UV radiation, and the relatively high
temperatures of theMediterranean climate. In contrast to other vegeta-
ble oils, which must be extracted from seeds using solvents to be made
edible, virgin olive oil retains almost all of the properties of olives, in-
cluding the chemical composition, biochemical status, and organoleptic
properties. In addition to complex environmental and agronomical fac-
tors, the average concentration of the minor constituents in virgin olive
oil also depends on technological factors [26].
Among the several minor constituents of virgin olive oil (Figs. 1–3),
the most abundant fraction is hydrocarbons (squalene and, in smaller
amounts, the carotenoids β-carotene and lutein). Other minor constitu-
ents of virgin olive oil include phytosterols, such as β-sitosterol,
Δ5-avenasterol, and campesterol, triterpenic compounds in the form
of dialcohols (erythrodiol and uvaol) or acids (oleanolic and maslinic
acids), and phenolic compounds, representing the polar fraction. The
main classes of phenolic compounds in virgin olive oil are secoiridoids,
as ester derivatives of elenolic acid in either its aglyconic form or glyco-
sylated with hydroxytyrosol (oleuropein) or tyrosol (ligustroside);
simple phenols, in the form of alcohols (tyrosol and hydroxytyrosol)
or acids (p-coumaric, o-coumaric, caffeic, ferulic, sinapic, gallic, gentisic,
syringic, vanillic, protocathechuic, and p-hydroxybenzoic acids);
hydroxyisochromans formed by the reaction between hydroxytyrosol
and benzaldehyde or vanillin; ﬂavonoids (luteolin, apigenin, and quer-
cetin); and the lignans (+)-pinoresinol, 1-(+)-acetoxypinoresinol,
and 1-(+)-hydroxypinoresinol. The lipophilic phenols include tocoph-
erols (α-, β-, γ-, and δ-tocopherols) and tocotrienols (α-, β-, γ-, and
δ-tocotrienols), with α-tocopherol as the predominant constituent in
virgin olive oil.
3. Oleic acid: membrane interactions and functions
After ingestion, lingual and pancreatic lipases hydrolyze the ester
bonds of virgin olive oil triacylglycerols, yielding 2 major digestion
products: sn− 2-monoacylglycerols (mainly sn− 2-monooleoylglycerol)
and FAs (mainly oleic acid). These products are then taken up byenterocytes, re-esteriﬁed into triacylglycerols, and incorporated with
other lipids (e.g., small amounts of cholesteryl esters, mainly cholesteryl
oleoyl ester), lipid-soluble vitamins, sugars, and apolipoproteins
(mainly apoB48) into chylomicrons for subsequent secretion into the
bloodstream. Similarly, the liver secretes very-low-density lipoproteins
(VLDLs), which are rich in endogenous triacylglycerols from FAs syn-
thesized de novo or taken up from the circulating pool of FAs complexed
with albumin. The triacylglycerols of chylomicrons and VLDLs undergo
hydrolysis by lipoprotein lipase, which is located at the surface of cells.
The uptake of FAs from the cell surroundings has long been thought to
occur via simple diffusion, a passive process dependent on the activity
of intracellular metabolism. This process involves the creation of a
trans-membrane, downhill concentration gradient and includes the
ﬂip-ﬂop molecular mechanism of FA transport [27] and membrane
transporters (e.g., FABPpm, FAT/CD36, FATP family proteins, and
caveolin-1), which facilitate FA endocytosis. In addition, chylomicrons
and VLDLs, which may or may not be affected by partial hydrolysis,
can be recognized by membrane receptors (e.g., apoB48 and VLDL
receptors) [28–31], internalized, and directed to the endosomal–
lysosomal system. Here, the sn− 1(3)-ester bonds in triacylglycerols
and the C-3 ester bond in cholesteryl esters are hydrolyzed by lysosomal
acid lipase, which produces signiﬁcant amounts of intracellular oleic acid
and sn− 2-monooleoylglycerol formembrane biogenesis, either by acyl-
ation of glycerophosphate to phosphatidic acid (via the Kennedy path-
way) or by remodeling of de novo synthesized glycerophospholipids via
deacylation–reacylation or via themonoacylglycerol pathway. The regu-
lar consumption of virgin olive oil increases the concentration (up to
15%) of oleic acid among the plasma membrane lipids [32–34].
3.1. Oleic acid in membrane lipid structure
Cell membranes contain hundreds of different lipid species,
which can be categorized into 3 main classes: glycerophospholipids,
sphingolipids, and sterols (cholesterol in animals) (Fig. 4). Cholesterol
contains a 4-membered cyclopentanophenanthrene ring structure, a hy-
droxyl group, and a short hydrophobic tail and imparts stiffness tomem-
branes, accentuating the potential hydrophobic incompatibility between
the hydrophobic transmembrane domains of proteins and the lipid
bilayer core [35]. Additional complexity of glycerophospholipids is
achieved through differences in the FA chains and their linkages by
ester bonds in the sn − 1 and sn − 2 positions and by alkyl ether or
alkenyl ether bonds in the sn − 1 position of the glycerol backbone.
The lipid backbone of sphingolipids is one molecule of ceramide
(sphingosine amide linked to a FA), which can be further modiﬁed
and extended with a phosphocholine head group or glycans to form
Fig. 1. Chemical structures of squalene, carotenoids, sterols, triterpenic dialcohols, and
triterpenic acids in virgin olive oil.
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part of our genome is required to synthesize, metabolize, and regulate
the pool of FAs for de novo biogenesis of membranes, and the role of
exogenous (dietary) FAs in these processes remains largely unknown.
The incorporation of oleic acid into the phospholipids of the cell
membrane can regulate the membrane structure and, in turn, alter the
biophysical properties of the membrane. The lamellar phase is recog-
nized as the most common lipid arrangement and is oriented perpen-
dicular to the membrane surface in cells. The ﬂuid lamellar phase
(Lα or liquid crystalline) is found in most membrane regions and
domains, such as coated pits, caveolae, synaptosomes, or lipid rafts
[liquid-ordered (l0) phase]; however, membrane lipids can also orga-
nize into non-lamellar phases (Lε frustrated membranes), including
hexagonal (HI and HII), cubic (micellar and bicontinuous), and rhom-
bohedral phases [37]. Unlike stearic acid and elaidic acid (trans-
18:1n − 9), oleic acid favors the organization of membranes into
HII non-lamellar phases, which drastically changes the temperature
range of the stability of the single Lα phase, decreasing the lamellar-
to-hexagonal (Lα-to-HII) phase transition temperature in lipid mem-
branes [38–40]. This propensity of oleic acid to stabilize the HII phase
and to induce a negative curvature strain on lipid bilayers is related to
the molecular shape of oleic acid. The cis double bond of oleic acid pro-
duces a bend at a ~120° angle in the middle of the carbon chain that
confers a boomerang-shaped structure. In elaidic acid (the trans isomerof oleic acid), the 2 parts of the carbon chain are almost linear, similar to
stearic acid, resulting in a rod-shape structure. Linear molecules pack
together closely in a given space and cause little disorganization of the
lipid bilayer, whereas bent molecules cannot pack together to form
such ordered and rigid arrays. The kinked lipid chain of oleic acid
reduces the order within the lipid bilayer, helps to maintain the hydra-
tion level, and increases membrane ﬂuidity [41,42]. Oleic acid and
2-hydroxyoleic acid (a synthetic, hydroxylated analog of oleic acid)
were recently reported to induce lateral lipid heterogeneity in a
model mimicking cell membrane structure [43]. Both FAs have a similar
ability to modulate the liquid-ordered/liquid-disordered structure ratio
and the microdomain lipid composition, conceivably affecting lipid
rafts [44,45]. The effects of different naturally occurring FAs (stearic,
α-linolenic, linoleic, eicosapentaenoic, docosahexaenoic, and arachi-
donic acids) and the corresponding synthetic 2-hydroxylated FA deriv-
atives were also compared, but the greatest disordering effect was
caused by oleic acid and 2-hydroxyoleic acid, suggesting that the pres-
ence of an 18-carbon acyl chain in combination with a single cis double
bond produced the most potent reorganizing effect on the model
membranes.3.2. Oleic acid in membrane lipid function
Oleic acid may have important consequences as an environmental
factor by altering some targeted molecular functions in the cell through
the modulation of membrane properties, while either embedded in the
membrane or in its free form upon release from the sn− 2 position of
phospholipids via phospholipases. In general, different proteins interact
with speciﬁc regions of the membrane, which are clearly aligned into
the l0 and Lε organizations [37]. For example, sterol regulatory
element-binding proteins (SREBPs) belong to a family of transcription
factors that orchestrates the expression of a broad array of genes re-
quired for the synthesis of cholesterol [by transcription of 3-hydroxy-
3-methylglutaryl CoA (HMG-CoA) reductase] and FAs (by transcription
of SCD1) [46]. SREBPs are anchored in the membrane of the ER via 2
trans-membrane domains and are subject to negative feedback regula-
tion by cholesterol and FAs [47]. This feedback mechanism is based on
the ability of unsaturated FAs to reduce degradation of insulin-
induced gene 1 (INSIG1), an ER membrane protein that plays a crucial
role in the SREBP cleavage-activating protein (SCAP)/SREBP transport
system for cholesterol synthesis and uptake [48,49]. After ubiquitylation
of INSIG1, oleic acid but not stearic acid blocks the binding of
ubiquitylated INSIG1 with the ubiquitin-like (UBX)-domain-containing
protein 8 (UBXD8), thereby circumventing ER-associated degradation
of INSIG1 by stabilizing INSIG1. INSIG1 then binds the polytopic mem-
brane protein SCAP, blocking the proteolytic activation of SREBP. This
decrease in cellular levels of cholesterol has been shown to induce a re-
arrangement of lipid rafts, thereby affecting the localization and activity
of integral proteins, including platforms (e.g., FAT/CD36) that facilitate
the binding and uptake of MUFAs and PUFAs [50].
As an example, one role for oleic acid in this complex dynamic mo-
tion of cross-sectional distribution in membrane lipids, which stabilizes
the bilayer structure and regulates the embedded proteins therein, has
been proposed for both the catalytic and proton-translocase activities
of urothelial V-ATPase [51]. Comparison of the effects of the supply of
oleic or linoleic acid to superﬁcial umbrella cell membranes of the
urinary bladder mucosa revealed that the ATP hydrolytic activity of
V-ATPase increases while the V-ATPase proton translocation rate de-
creases in oleic acid-rich membranes of urothelial endocytic vesicles.
Similar ﬁndings were observed when the activity of the Na/K-ATPase
was explored in reconstituted systems containing membrane lipids
bearing FA chains of different lengths and degrees of unsaturation,
supporting an uncoupling or slippage phenomenon analogous to that
observed in P-ATPase-type ion pumps [52]. Accordingly, oleic acid is
proposed to mediate an increase in the minimal hexagonally packed
Fig. 2. Chemical structures of secoiridoids, phenyl-alcohols, and phenyl-acids in virgin olive oil.
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ATPase function in the membrane urothelium.
Due to its ability to organize membranes into Lε frustrated lamellar
phases, oleic acid facilitates membrane docking and activity of other
amphitropic proteins. Thus, Lε domains delineate regions for the re-
cruitment and interaction of heterotrimeric Gαβγ proteins, G-protein-
coupled receptors (GPCRs), and related signaling molecules; by con-
trast, l0 regions form domains that enable the interaction of dissociated
Gα subunits from the Gβγ dimers with effector proteins [37,53]. GPCRs,
which are the largest family of membrane-spanning proteins (~800
members in the human genome), can detect an expansive array of
extracellular signals or ligands, including photons, ions, odors,
pheromones, hormones, and neurotransmitters [54,55]. In addition to
oleic acid-induced rearrangement of lipid bilayer structure into HII
nonlamellar phases, the activation of heterotrimeric Gαβγ proteins
induces conformational changes in the immediate lipid environment.
The Gα subunit exchanges bound GDP for GTP and dissociates from
theGβγ dimer, which retains its afﬁnity for hexagonal-phasemembrane
regions close to GPCRs [56]. Post-translational modiﬁcation of
heterotrimeric Gαβγ proteins, including myristoylation, palmitoylation,and isoprenylation, also favors the anchoring of proteins to the mem-
brane and the formation of non-lamellar-prone regions [56]. Further-
more, oleic acid regulates G-proteins concentrated in lipid raft/caveolae
domains. The G-protein-coupled growth hormone (GH) secretagogue
receptor (GHSR), which is activated by ghrelin, has been shown to
assemble into lipid rafts [57]. Ghrelin binds to GHSR and provokes in-
creased levels of intracellular diacylglycerol, inositol 1,4,5-triphosphate
(InsP3), and Ca2+ by the action of phospholipase Cβ1 (PLCβ1α/β) on
membrane phosphatidylinositol via Gq/11α proteins [58]. Oleic acid
markedly improves the response of GHSR to ghrelin via a mechanism
that involves the suppression of ligand-induced receptor internalization
by blocking GHSRmembrane-trafﬁcking and uncoupling GHSR from the
endocytic pathway [59]. Notably, the responses of other GPCRs, such as
the 5-hydroxytryptamine 7A (5-HT7A) receptor, are selectively stimu-
lated by oleic acid, which confers more efﬁcient ligand coupling of the
5-HT7A receptor with Gsα subtypes of G proteins in the environment
of lipid rafts [60]. Therefore, oleic acid providesmultiple adaptivemem-
brane sites for the plasticity of GPCRs, whereas G-proteins promote and
perpetuate the concurrence of dynamic multi-domain systems of non-
lamellar membranes with ﬂuid lamellar phases.
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Fig. 3. Chemical structures of hydroxyisochromans, ﬂavonoids, lignans, tocopherols, and tocotrienols in virgin olive oil.
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Accumulating data frommultiple lines of evidence suggest that die-
tary FAs are linked not only to the promotion of health but also to the
pathogenesis of disease. In particular, oleic acid from virgin olive oil
has been shown to have beneﬁcial effects in reducing the risk of major
chronic diseases [3,9,11,12,15], many of which are associated with
abnormalities in the type and/or abundance of the lipids in cell mem-
branes [37].
In contrast to the consumption of soybean oil (which is rich in linoleic
acid and low in oleic acid), virgin olive oil intake has been shown to in-
duce a marked reduction in blood pressure in hypertensive animals
[61]. This effect was not only acute (with a post-prandial peak at
2–4 h) and stable for 3–4 days but was also sustained after the adminis-
tration of virgin olive oil for 2 weeks. Importantly, the administration of
oleic acid, but not stearic or elaidic acid, mimicked the hypotensive ef-
fects of virgin olive oil. Theseﬁndings suggest a scenario inwhich the sig-
naling pathways of adrenergic receptors (α- and β-adrenoreceptors),
key elements in the central and peripheral control of blood pressure,
are affected by the increase in HII-prone membrane regions in response
to the administration of virgin olive oil or oleic acid. Several lines of evi-
dence indicate adaptive changes in the bilayer structure to support the
regulation of the α2-adrenoreceptor/G protein/adenylyl cyclase-cAMP/
protein kinase A (PKA) vasodilatory pathway [62–64]. First, membranes
from the aorta of animals feature reduced expression of G-proteins, in-
cluding Gαi2, Gαi3, Gαq/11, and PLCβ1α/β. Second, the reduction inblood pressure correlated with a decrease in the Lα-to-HII phase transi-
tion in aorticmembranes and an increase in the dose of oleic acid admin-
istered to the animals. The effect of oleic acid on blood pressure
reduction is mediated, at least in part, by an enhanced production of
vasodilatory stimuli (e.g., cAMP and PKA) and a decrease in vasoconstric-
tion pathways (InsP3, Ca2+, diacylglycerols, and Rho kinase). This con-
clusion is supported by earlier studies demonstrating that the ingestion
of virgin olive oil reduces blood pressure [32,65] as well as the need for
antihypertensive medication [66] in humans.
Glucose uptake from the bloodstream is the rate-limiting step in
whole-body glucose utilization and is regulated by speciﬁc transporter
GLUT membrane proteins. Normal glucose transport and utilization is
critical for preventing glucose intolerance that leads to insulin resis-
tance and the development of type 2 diabetes [67]. Members of the
GLUT family (which includes 14 GLUT proteins in humans) are encoded
by the solute carrier member 2 (SLC2) genes and are composed of ~500
amino acid residues. GLUT family members are categorized into 3 clas-
ses based on sequence similarity: Class 1 (GLUTs 1–4 and 14), Class 2
(GLUTs 5, 7, 9, and 11), and Class 3 (GLUTs 6, 8, 10, 12, and HMIT).
GLUTs are integral membrane proteins that contain 12 membrane-
spanning helices, a single N-linked glycosylation site, and a relatively
large, central cytoplasmic linker domain and feature topologies in
which both their N and C termini are exposed on the cytoplasmic side
of the membrane. GLUT4 is the predominant isoform expressed in
insulin-sensitive tissues, fat, and muscle. The insertion of GLUT4 into
the plasma membrane and fusion with insulin-dependent docked
OFig. 4. Chemical structures of glycerophospholipids and sphingolipids containing oleic acid chains.
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and SFAs in the phospholipids of model membranes [42], suggesting
that membranes rich in oleic acid and poor in SFAs have increased ﬂex-
ibility and promote the capacity for GLUT4-dependent glucose transport
into cells. In a mouse skeletal cell line, oleic acid has been shown to re-
verse SFA-induced impairment of insulin-responsive GLUT4 recycling
by preventing aberrant PKCθ activation [68]. These ﬁndings are in agree-
ment with human studies demonstrating that dietary fats rich in oleic
acid and poor in SFAs improve insulin sensitivity in the post-prandial
state [69,70]. Type 2 diabetes is commonly linked with nonalcoholic
fatty liver disease; however, the impact of FAs on hepatic membranes
and the intolerance of hepatic cells to insulin remain poorly understood
and controversial [71].More evident is theprotective effects of oleic acid,
when incorporated into hepatic membranes, against models of drug-
induced liver toxicity [72] or aging-related liver apoptosis [73].
There is increasing evidence that lipid raftsmay be targets for neuro-
nal development and regeneration, highlighting the potential for lipid-
based strategies against progressive neurodegenerative disorders such
as Alzheimer's disease (AD) [74,75]. Neuronal lipid rafts are involved
in cellular polarity as well as pro-survival and pro-growth receptor sig-
naling pathways for neuronal sprouting [76] and are found in themem-
brane sites surrounding pre- and post-synaptic proteins [77]. An
additional event in neuronal membrane repair is the coalescence of
smaller-scale lipid rafts into larger lipid rafts through lateral membranedistribution, which occurs via lipid–lipid and lipid–protein interactions.
In neurons, oleic acid activates peroxisome-proliferator-activated
receptors, promoting axonal growth, neuronal clustering, and the tran-
scription of key genes for neuronal differentiation, including neurogenic
basic helix-loop-helix/neuronal differentiation protein-2 (NeuroD2),
axonal growth-associated protein-43 (GAP43), and microtubule-
associated protein-2 (MAP2) [78–80] Detailed postmortem analysis of
FAs in lipid rafts in the frontal cortex grey matter of patients who suf-
fered from severe Alzheimer's-type dementia compared to samples
from neurologically normal individuals revealed a signiﬁcant decrease
in oleic and docosahexaenoic acids [74]. The most striking observation
was the negative relationship between oleic and stearic acids in lipid
rafts. This observation suggests that oleic acid is important for preserv-
ing the homeoviscous state of membranes in neuronal cells. In support
of this concept, oleic acid decreases the levels of the toxic amyloid-β
peptide, which reciprocally interacts with cholesterol in lipid rafts
[81], and amyloid plaques in a mouse model of AD [82]. Furthermore,
the incorporation of oleic acid into membranes of neuroblastoma cells
reduces the toxic effects of palmitic acid and rescues cells from apopto-
sis [83]. The incorporation of oleic acid into the brain mitochondrial
membranes after the administration of virgin olive oil could also reduce
oxidative stress associated with age [84].
The deprotonated formof oleic acid also plays an active role as a lipid
cofactor of partially unfoldedα-lactalbumin in the tumoricidal action of
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tumor cells), which induces membrane disruption in tumor cells but
not healthy cells [85–89]. In contrast to SFAs, PUFAs, and trans-
MUFAs, oleic acid shares speciﬁc structural features required for both
optimal HAMLET formation and engagement of targets involved in
tumor cell death. Membrane binding studies with a HAMLET-like
substance (BLAOA, bovine α-lactalbumin complexed with oleic acid)
suggest that acyl-chain mismatch or immiscibility of membrane lipid
components may provide local sites for HAMLET interaction and
accumulation. The negative intrinsic curvature of oleic acid and the
bilayer-penetrating helix in the partially unfolded α-lactalbumin more
easily disrupt the membrane by blebbing, with subsequent shedding
of small lipid aggregates, causing the membrane to collapse [90]. In
addition to interaction with tumor cell membranes, HAMLET becomes
rapidly internalized and translocates into the nucleus [91]. The
conserved death response of tumor cells to HAMLET is dependent on
oncogenic transformation, proteasome inhibition, nucleosome-histone
binding, mitochondrial damage, and ion channel activation. The inter-
actions of HAMLET with membranes as well as subsequent biological
perturbations in tumor cells all require both the protein and oleic acid.
4. Minor constituents: membrane interactions and functions
4.1. Squalene
Squalene is a polyunsaturated aliphatic hydrocarbon that contains 6
isoprene units. It is structurally related to β-carotene, ubiquinol-10
(reduced form of coenzyme Q10), and vitamins K1, D, and E. In virgin
olive oil, squalene is protected fromoxidation, and squalene confers sta-
bility to virgin olive oil [92,93]. The content of squalene in virgin olive oil
ranges from 800 to 12000 mg/kg, accounting for more than 50% of the
unsaponiﬁable fraction of virgin olive oil. In humans, approximately
60 to 85% of dietary squalene (up to 200 mg/day) is absorbed and dis-
tributed ubiquitously by triacylglycerol-rich lipoproteins in tissues,
with the greatest accumulation in the skin [94]. However, squalene
can be endogenously synthesized by sequential reactions in which
HMG-CoA is ﬁrst converted to farnesyl pyrophosphate, followed by
head-to-head condensation of 2 molecules of farnesyl pyrophosphate
catalyzed by squalene synthase, and reduction by NADPH to yield squa-
lene. Squalene is an important precursor in the formation of eukaryotic
sterols and bacterial hopanoids. For the biosynthesis of cholesterol, the
enzymes squalene monooxygenase and oxidocyclase convert squalene
into the cyclic derivative lanosterol, which is converted to cholesterol
via a series of 19 reactions. SREBPs mainly regulate the transcription
of the rate-limiting enzymeHMG-CoA reductase [95]. However, choles-
terol can also feed back to stimulate the proteasomal degradation of
squalene monooxygenase as an additional post-translational control
point in the regulation of sterol biosynthesis pathways and to preserve
the demand for the isoprenoids farnesol and geranylgeraniol [96].
Farnesylation and geranylgeranylation of members of the Ras super-
family of GTPases and other membrane proteins have been shown to
be critical in the correct targeting of these proteins to the inner surface
of the plasma membrane [53].
In spite of its nonpolar nature, squalene can be partitioned within
the hydrophobic core of the lipid bilayer, with the extended length—
or the coiled conformation [97]—oriented parallel to the membrane
phospholipid chains and in the center plane of the bilayer. In this con-
formation, squalene plays a major role in maintaining the electrochem-
ical gradient that moves ions across membranes [98]. Studies of model
membranes of giant vesicles, which mimic the native environment of
mammalian cells for the study of membrane lipid–protein interactions,
have revealed that squalene increases the polarity and hydrophobic
interactions of reconstituted trans-membrane-spanning regions of
pore-forming proteins such as aquaporins, facilitating the functional
regulation of these proteins as well as the trans-membrane route for
watermovement [99]. The stabilizing effects of squalene onmembranesare related to the increased rigidity and size of regions adopting the in-
verse hexagonal HII phase [100,101]. This dynamically folded conforma-
tion of squalene is retained when linked to gemcitabine, a synthetic
tumoricidal pyrimidine nucleoside, leading to self-organized, stable,
and mono-dispersed nanoparticles composed of inverse hexagonal
phases that increase gemcitabine amphipathy and improve gemcitabine
diffusion through lipidmembranes [102,103]. Grafting of the squalenoyl
moiety onto the gemcitabine molecule accelerates gemcitabine diffu-
sion within cholesterol-rich domains, indicating squalenylation as a
new nanotechnology platform for targeted delivery of drugs with anti-
cancer and antiviral properties [104,105].
The natural enrichment of squalene in skin surface lipids suggests
that this terpene molecule protects against external chemical, physical,
or microbial signals and stressors on the skin surface [94]. The most in-
tensely researched ﬁeld is solar UV irradiation (UVB, 290–320 nm; UVA,
320–400 nm), with efforts attempting to target the increased risk of
tumor development associated with UV overexposure. Molecules such
as DNA, trans-urocanic acid, melanin precursors, tryptophan, and
endogenous or bacterial porphyrins can selectively absorb in the UV
wavelength range (mainly UVA) and hence catalyze oxidative cyto-
static, cytotoxic, or immunomodulating photoreactions. When the
α-tocopherol and ubiquinol-10 line of defense is overwhelmed, a
wide range of relatively hydrosoluble by-products of varying polarity
and reactivity are rapidly generated by oxidative degradation of squa-
lene, which is the most efﬁcient quencher of singlet oxygen in skin
surface lipids [94,106]. Oral administration of squalene decreases
UV-induced DNA damage and prevents photo-aging in human skin
[107]. In addition to its radical scavenging capacity (either alone or in
virgin olive oil) in membranes and skin disorders [108,109], squalene
is effective against several degenerative diseases [4,110–112] and has
been used as a vaccine adjuvant [113].
4.2. β-Carotene and lutein
Carotenoids are polyenoic terpenoids with 8 condensed isoprene
units containing conjugated trans double bonds. They include the family
of carotenes (e.g., β-carotene) and xanthophylls (e.g., lutein). Carotenes
are pure hydrocarbons and contain no oxygen atoms, whereas xantho-
phylls contain oxygen atoms within hydroxyl groups and/or epoxides.
Carotenoids are ubiquitous constituents in themembranes of all photo-
synthetic organisms and are essential for the assembly and stability of
protein complexes and for membrane dynamics via carotenoid–lipid–
protein interactions in thylakoid membranes [114]. They also have
photoprotective properties and participate in protecting elongation fac-
tors of the translational machinery from stress damage in the mem-
branes of green plants and other types of photosynthetic organisms.
Carotenoids cannot be synthesized by vertebrates de novo and thus
are sequestered from the diet. In virgin olive oil, the content ofmajor ca-
rotenoids ranges from4 mg/kg forβ-carotene to 10 mg/kg for lutein, al-
though virgin olive oil also contains β-cryptoxanthin and 5,6-epoxy
xanthophylls, including neoxanthin, violaxanthin, antheraxanthin, and
their furanoxides [115,116]. Carotenoids are susceptible to reactions
including isomerization (trans to cis) and oxidation, which increase
the average shelf life of virgin olive oil [117].
Carotenoids levels in human blood and tissues are critical for main-
taining human health. In the intestinal mucosa, approximately half
of the dietary β-carotene is irreversibly converted to 11-cis-retinal via
β-carotene 15,15′-monooxygenase (BCMO1) activity. Retinal is then re-
duced to retinol (vitamin A) by retinol dehydrogenases (stoichiometric
conversion of 2 mol of retinol formed per 1 mol of β-carotene cleaved)
[118,119]; the β-ionone ring also converts pro-vitamin A (1 mol of
retinol) to β-cryptoxanthin [120]. Retinal can also be oxidized to
retinoic acid. The capacity of the liver to metabolize β-carotene is 4
times greater than that of the intestine [121]. The absorption of retinol
and intact carotenoids is affected by several dietary factors, including
the food matrix and interactions between carotenoids and other food
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[120,122]. Lutein is the most abundant carotenoid in human
triacylglycerol-rich lipoproteins after the ingestion of virgin olive oil
[123]. The retinol metabolite retinoic acid, via retinoic acid and X recep-
tors, may modulate the expression of the homeobox transcription factor
ISX, which represses the expression of BCMO1 and membrane protein
transporters involved in retinol and carotenoid intestinal absorption
[120,124].
In biological membranes, carotenoids are present as carotenoid-
protein complexes and as direct components of the lipid phase, demon-
strating an ability to form self-assemblies [125]. The conformation of ca-
rotenoids in membranes is of great importance because the energy
associated with spectroscopic transitions is directly related to the anti-
oxidant properties exhibited by carotenoids in lipid environments
[126]. According to the most recent study of atomistic molecular dy-
namics simulations of β-carotene and zeaxanthin (a structural isomer
of lutein) immersed in a model lipid membrane [127], β-carotene can
adopt a relatively ﬂat proﬁle along tilt angles of the polyenic chain—
with respect to the membrane normal axis—from 90° (perpendicular
to lipid tails) to 35°. Three minimal energy proﬁles for the simulations
of β-carotene were observed at 90°, 60°, and 40°, indicating substantial
variability of the orientation of β-carotene within membranes. The
orientation axis of β-carotene, which is nearly parallel with the mem-
brane surface within hydrophobic tails, displays a broad distribution of
the β-ionone ring centered at one of the leaﬂets. The average tilt angle
for zeaxanthinwas lower (approximately 30°), likely due to electrostat-
ic interactions between the hydroxyl groups of zeaxanthin with the
polar lipid heads of themembrane. By contrast, the entire ε ring of lutein
can rotate around the C6′–C7′ bond, which facilitates the interaction of
the hydroxyl groups located at the opposite ends of the molecule with
the same polar membrane surface [128] and the unambiguous orienta-
tion following the pattern of zeaxanthin and parallel with respect to the
plane of themembrane [129]. This result is in agreementwith a speciﬁc
position of lutein involving one membrane-spanning segment and one
horizontally oriented segment and with the tendency of lutein to
accumulate in the liquid-disordered phase of membranes [130]. These
studies are also consistent with the β-carotene-mediated induction of
membrane lateral asymmetry by lateral diffusion and a decrease in
the lipid membrane surface area, as opposed to the rigidity of mem-
branes containing lutein [114,131]. The lower effective conjugated
chain length for β-carotene predicts a lesser antioxidant character
than lutein within membranes through enhanced charge donation
and reduced charge acceptance [126,132]. Differences in themembrane
spatial distribution of β-carotene and lutein, as well as subsequent dif-
ferences in their antioxidant properties, may constitute an advantage
to synergistically trap in-tandem (lutein→ β-carotene) triplet-excited
molecules of sensitizers, singlet oxygen, or free radicals and to prevent
the propagation cycle of lipid peroxidation from the interface of the
membrane to the inner region of the membrane. In support of this no-
tion, there is evidence that unpaired electrons ﬂow from the oxidative-
derived radical cations of astaxanthin, which is anchored in the lipid/
water interface, to β-carotene in the inner portion of the membrane.
The resulting β-carotene radical cation tends to rotate and move toward
the polar interface in the membrane, facilitating the regeneration of
β-carotene by interaction of the β-carotene radical cation with ascor-
bate or α-tocopherol [133].
In the rod outer segment disc membranes of photoreceptor cells,
the visual pigment rhodopsin is a retinal photoreceptor protein
(a prototypical GPCR) of bipartite structure consisting of the transmem-
brane protein opsin and the light-sensitive chromophore 11-cis-retinal.
The reactions that eventually result in the conversion of light energy
(photons) into a photoreceptor electrical response require a constant
supply of 11-cis-retinal from β-carotene and pro-vitamin A carotenoids.
The retina is very sensitive to oxidative stress and lipid peroxidation due
to abundant illumination, high respiratory demands for oxygen, and a
large presence of docosahexaenoic acid, which contains 6 double bondsand thus is easily oxidized. To prevent oxidative damage to the retina, lu-
tein (zeaxanthin andmeso-zeaxanthin—a metabolite of lutein) accumu-
lates at very high concentrations in themacula lutea (up to 1 mM in the
central fovea) via the involvement of speciﬁc carotenoid-binding pro-
teins [StAR-related lipid transfer domain protein 3 (StARD3), for lutein]
[134]. Lutein exhibits high efﬁciency in protecting against lipid peroxida-
tion in membranes composed of raft-forming mixtures as well as in
models of photoreceptor outer segments [135] andmodulates the prop-
erties of lipid raft functions aroundmembrane proteins such as the tran-
sient receptor potential A1 (TRPA1) ion channel in primary sensory
neurons [136]. There is clinical evidence that lutein,β-carotene, and vita-
mins C and E reduce the risk of age-related macular degeneration
[137,138]. These carotenoids have also been proposed to favor optical
density of the macular pigment [139] and protect against age-related
cataracts [140], cognitive decline [141], atrial ﬁbrillation [142], osteopo-
rotic fractures [143], and vascular aging [144].
4.3. β-Sitosterol, Δ5-avenasterol, and campesterol
While cholesterol is the major sterol in animals, β-sitosterol,
Δ5-avenasterol, and campesterol, in addition to brassicasterol and stig-
masterol, are the most commonly occurring sterols (phytosterols) in
the plant kingdom. These sterols are structurally similar and contain 4
strongly hydrophobic hydrocarbon rings (planar steroid nucleus), a
hydroxyl group at the 3-carbon atom of the A-ring, and an alkyl tail
(side chain). Therefore, these molecules display amphipathic proper-
ties. Phytosterols differ from cholesterol only by an additional ethyl
group (β-sitosterol) or methyl group (campesterol) at the 24-carbon
atom or by an additional trans double bond at the 22-carbon atom (stig-
masterol, as compared to brassicasterol) in the side chain. Carbon atom
24 in β-sitosterol and campesterol has R chirality, whereas the equiva-
lent carbon atom in brassicasterol and stigmasterol has S chirality and
lower ﬂexibility due to the trans conﬁguration of the side chain double
bond [145]. Mammals do not synthesize phytosterols endogenously.
The sterol β-sitosterol is the most abundant in virgin olive oil, compris-
ing 80% to 92% of the total sterols (at least 1000 mg/kg, with a maxi-
mum of 3000 mg/kg). Following β-sitosterol, the most important
sterols in virgin olive oil are Δ5-avenasterol (4–14%) and campesterol
(0.5–4%). These constituents help maintain virgin olive oil stability by
inhibiting polymerization reactions during heating at frying tempera-
ture. The sterol proﬁle is affected by the olive fruit variety and the de-
gree of ripening [146,147] and is considered a ﬁngerprint for authentic
virgin olive oil [148,149].
When β-sitosterol is added to mixed micelles (model intestinal
solutions) containing bile salts, phosphatidylcholine, FAs, and cholester-
ol, there is a speciﬁc, sharp decrease in the maximum solubilization
of cholesterol that is dependent on the preferential solubilization of
β-sitosterol at similar micellar solubilization sites according to the
strength of afﬁnity [150]. This restriction due to dynamic competition
of cholesterol and β-sitosterol in processes of self-assembly of nutrients
in the intestinal lumen may explain the ability of β-sitosterol to
decrease the rate of cholesterol transport to the intestinal wall, which
is one of the main molecular mechanisms of phytosterol action
on cholesterol plasma levels. The polytopic Niemann–Pick C1-Like1
(NPC1L1) trans-membrane protein is required for phytosterol (and cho-
lesterol) entry in enterocytes [151]. Phytosterols and non-esteriﬁed cho-
lesterol are pumped back into the intestinal lumen via the ATP-binding
cassette sub-family G-member proteins ABCG5 and ABCG8 or may be
transported to the basolateral membrane of the enterocyte for ABCA1
(ATP-binding cassette sub-family A member 1)-mediated biogenesis of
HDLs (high-density low lipoproteins), whereas cholesterol is esteriﬁed
via the enzyme acetyl-coA acetyltransferase 2, packed into chylomicrons,
and drained into the lymph system [152]. These complex mechanisms
are responsible for the assimilation of approximately 50% of dietary cho-
lesterol and less than 5% of phytosterols. Notably, virgin olive oil intake
induces an increase in the plasma levels of β-sitosterol, which is
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and the plasma levels of total cholesterol and LDLs (low-density lipopro-
teins) in asymptomatic elderly people at high cardiovascular risk [153].
Bothβ-sitosterol and FAs (oleic acid and PUFAs) can act as signalingmol-
ecules for the transcriptional repression of NPC1L1 in the intestine and
liver [154]. These pathways lead to the insertion of β-sitosterol and,
eventually, other phytosterols into membranes and the partial replace-
ment of cholesterol.
β-Sitosterol has lower condensing and ordering potency than
cholesterol in binary and multicomponent model membranes com-
posed of phosphatidylcholine, sphingomyelin, ganglioside, and/or cer-
amide [155]. In conjunction with the similar in-plane organization of
β-sitosterol and β-sitostanol (a saturated form of β-sitosterol) in Lang-
muir monolayers of glycerophospholipids [155,156], these data suggest
that the alkyl tail, rather than the ring structure, in β-sitosterol accounts
for the difference in membrane organization compared with choles-
terol. Interestingly, disturbances in the molecular packing and mor-
phology of model membranes due to the replacement of cholesterol
by β-sitosterol are more pronounced when glycerophospholipids have
MUFA chains compared with SFA chains [156]. Accordingly, atomistic
molecular dynamics simulation studies on lipid matrices reminiscent
of rafts (rich in saturated lipids) or less ordered membranes (rich in
unsaturated lipids) have shown that the lower cholesterol tilt and the
best ordering as a function of tilt in saturated bilayers promotes higher
ordering of the neighboring acyl chains [157,158]. As expected, phytos-
terols are inferior to cholesterol in promoting the formation of
membrane domains and can inhibit the incorporation of exogenous cho-
lesterol into lipid rafts at a molar ratio of 1:4 (cholesterol:phytosterol)
[159]. Therefore, the incorporation of increasing amounts of phytosterols
into bilayers could gradually diminish the l0 phase. The magnitude of
these effects depends on the geometry of the phytosterol because the
transition temperature from the lamellar to Lα phase in bilayer vesicles
is reduced according to the following order of strength (compared to
cholesterol): β-sitosterol N stigmasterol N campesterol N cholesterol
[160]. This indicates that β-sitosterol is the least favorable phytosterol
for stabilizing the interactions of lipid molecules constituting mem-
branes. In binary phosphatidylcholine/sphingomyelin model mem-
branes, β-sitosterol also induces a stronger contraction of area per lipid
than stigmasterol [161].
The cholesterol-lowering effects of phytosterols (mainly β-sitosterol)
in plasma and cell membranes have been shown to maintain cardiovas-
cular health [162–164]. Circulating β-sitosterol, Δ5-avenasterol, and
campesterol are biomarkers for predicting glucose intolerance, and
Δ5-avenasterol and campesterol confer lower risk for type 2 diabetes
[165]. Furthermore, several studies have reported that phytosterol and,
in particular, β-sitosterol supplementation replaces cholesterol and
reduces growth and survival signals routed through caveolar rafts in
membranes of several cancer cell lines [155,156]. In some types of
cancer, the feedback regulation of cholesterol absorption and the lost of
endogenous cholesterol synthesis result in the formation of regions
prone to lipid raft development in the membranes of cancer cells
[166–168]. Among themanymechanisms bywhich phytosterols exhibit
anti-cancer activity in vitro are the modulation of ceramide metabolism,
liver X receptor activation, cell cycle progression, and apoptosis [169].
Inmice, increased circulating levels of phytosterols result in elevated
levels of phytosterols in the brain, most likely via delivery to the endo-
thelial cells of the blood–brain barrier followed by subsequent re-
secretion from the basolateral plasma membrane [170]. This accumula-
tion of β-sitosterol is relatively lower than campesterol, and the process
is virtually irreversible [171]. Within the brain, in a cell-type speciﬁc
manner, β-sitosterol can modulate the expression of genes involved
in lipid uptake and metabolism. The substitution of approximately
10% of membrane cholesterol by β-sitosterol reduces processing of
α-secretase-mediated amyloid precursor protein (APP) in lipid rafts
and promotes the speciﬁc re-distribution of APP, which impedes its
cleavage by α-secretase, in non-raft regions of hippocampal cells[172]. Studies of platelets, which contain more than 95% of circulating
APP, have revealed that β-sitosterol displaces cholesterol from lipid
rafts, inhibits high-cholesterol-induced platelet amyloid-β peptide
efﬂux, and increases pathways (β- and γ-secretase activities) for APP
processing [173]. β-Sitosterol also enhances mitochondrial function by
promoting inner mitochondrial membrane ﬂuidity in hippocampal
cells [174]. These anti-amyloidogenic and brain ATP-preserving/
boosting effects of β-sitosterol suggest its potential for use in the pre-
vention and management of neurodegenerative diseases such as AD.
4.4. Erythrodiol, uvaol, oleanolic, and maslinic acids
Naturally occurring triterpenic compounds in the form of dialcohols
(erythrodiol and uvaol) or acids (oleanolic andmaslinic acids) are com-
posed of 30-carbon atom skeletons structured as 5 6-membered rings.
Erythrodiol and uvaol are 2 triterpenic compounds that are widely dis-
tributed in the plant kingdom, either in free form or esteriﬁedwith FAs,
whereas oleanolic acid and maslinic acid are found as free acids or as
part of triterpenoid saponins. In the olive fruit, the methyl group at
the 28-carbon atom of α- and β-amyrins can be substituted by a hy-
droxymethyl group to give uvaol and erythrodiol or by a carboxylic
group to give ursolic and oleanolic acids. An additional hydroxyl group
at the 2-carbon atom of oleanolic acid yields maslinic acid [175].
Therefore, uvaol (ursan-12-en-3β,28-diol) and ursolic acid (ursan-12-
en-3β-ol-28-oic acid) have the carbon skeleton of ursane (derived
from α-amyrin), whereas erythrodiol (olean-12-en-3β,28-diol),
oleanolic acid (olean-12-en-3β-ol-28-oic acid), and maslinic acid
(olean-12-en-2α,3β-diol-28-oic acid) have the carbon skeleton of
oleanane (derived from β-amyrin). Erythrodiol and uvaol account for
approximately 60% and 40% of triterpenic dialcohols, respectively.
Oleanolic and maslinic acids account for 98–99% of mono- and di-
hydroxy pentacyclic triterpenic acids. The complete sequence of these
reactions occurs in the green epicarp of the olive fruit as well as in the
leaf and are signiﬁcantly inﬂuenced by olive variety and the progression
of olive fruit or leaf ontogeny [146,147,176,177]. Together with sterols,
erythrodiol and uvaol are relevant markers for authenticating the gen-
uine virgin olive oil and detecting adulteration. The sum of erythrodiol
and uvaol in virgin olive oilmust be less than4.5% of the total sterol con-
tent [149]. The concentrations of these non-steroidal triterpenic com-
pounds in virgin olive oil are approximately 75 mg/kg erythrodiol,
20 mg/kg uvaol, 100 mg/kg oleanolic acid, 50 mg/kg maslinic acid,
and 4 mg/kg ursolic acid [147,178].
Pentacyclic triterpenic acids alter the membrane phase properties
induced by cholesterol; the anisotropy and the nonuniformity of the bi-
layer environment also inﬂuence the relative position of pentacyclic
triterpenic acids in synthetic model membranes [179]. Ursolic and
maslinic acids partition into ﬂuid lipid domains close to the mem-
brane–water interface and compete with cholesterol to form hydrogen
bondswith carbonyl oxygen atoms in neighboring lipid acyl chains. This
partitioning induces the segregation of cholesterol within the bilayer
and inverted micellar (HII phase) structures. By contrast, oleanolic acid
penetrates more deeply into membranes, may adopt a parallel stacking
conformation [180], and acts to alter the presence of l0 cholesterol-rich
domains. In the membranes of human keratinocytes, oleanolic and
ursolic acids are integrated to a similar extent into lipid rafts, but only
oleanolic acid has the ability to inhibit the release of ceramides in re-
sponse to UVA radiation [181]. Structure-activity analysis indicates
that chemical functions at key positions on ring E (a carboxylic group
at the 17-carbon atom, which is near 2 methyl groups on the 20-
carbon atom) are essential for enabling lipid raft stabilization by tight
packing of oleanolic acid with sphingolipids in a manner resembling
that of cholesterol. In agreement, the geminal methyl groups in the
oleanane scaffold contribute differently to the efﬁciency of biological ac-
tivities when compared to the vicinal methyl groups in the ursane scaf-
fold [182]. Ceramides from plasmamembrane-localized sphingomyelin
immediately self-associate and form ceramide-enriched membrane
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the replacement of cholesterol by ceramides in rafts [184] but also facil-
itates cell death pathways [185]. Substantial amounts of ceramide,
either by de novo synthesis or via the action of acid or neutral
sphingomyelinase, are present in isolated rafts/caveolae, even in stimu-
lated cells [186]. Therefore, membrane ordering by oleanolic acid could
be a mechanism for limiting the transverse motion of ceramide mole-
cules as well as signaling that stems from these domains.
Pentacyclic triterpene dialcohols and acids have been shown to
decrease in vitro LDL susceptibility to oxidation [187], in vitro mem-
brane lipid peroxidation [188,189], plasma lipid levels and blood pres-
sure [190,191] (by promoting nitric-oxide-dependent vasorelaxation
[192,193]) in experimental hypertension, and ex vivo secretion of pro-
inﬂammatory cytokines in human peripheral blood mononuclear cells
[194]. These molecules also have vasodepressor, cardiotonic, and
antidysrhythmic activity in animal models [195] and modulate prosta-
glandin I2 synthesis in human coronary smooth muscle cells [196].
The potency in protecting LDLs against oxidation is as follows: maslinic
acid N uvaol N erythrodiol [187]. Maslinic acid and uvaol block LDL
binding sites prone to oxidative processes, but maslinic acid also
scavenges free radicals. Uvaol and erythrodiol are the most effective in
preventing LDL-supported thrombin generation. Oleanolic acid has pro-
tective effects against hepatic insulin resistance [197], inﬂammation
[198,199], and thrombosis [198] and is a potent endogenous agonist
of the G-protein-coupled bile acid receptor TGR5—a novel pharmaco-
logical target for the treatment of metabolic syndrome [200]—via
activation of subunit Gαs in lipid rafts [201]. Recent evidence suggests
a relevant role for oleanolic acid in the prevention of type 2 diabetes be-
cause the regular consumption of virgin olive oil enriched in oleanolic
acid improved outcomes in prediabetic patients with impaired fasting
glucose and impaired glucose tolerance [202]. In addition, erythrodiol,
uvaol, oleanolic, and maslinic acids inhibit the growth of tumor cell
lines from various human cancers, including colon, brain, and breast
cancer [203–207]. Oleanolic acid can suppress migration and invasion
[208] and potentiate the radiosensitivity [207] of tumor cells and
enhance the activity of antitumor drugs [209]. Due to the high tumor
uptake and tumor-speciﬁc targeting of oleanolic acid, new hybrid
radiolabeled nanoparticles containing oleanolic acid have been experi-
mentally used in an all-in-onemultimodal imaging system for the diag-
nosis and therapeutic monitoring of tumors [210]. Erythrodiol and
oleanolic acid are also effective against experimental autoimmune
encephalomyelitis by restricting the inﬁltration of inﬂammatory cells
into the central nervous system and preventing disruption of the
blood–brain barrier, suggesting their potential for the prevention and
management of multiple sclerosis and other autoimmune and/or
neuro-inﬂammatory diseases [211].
4.5. Secoiridoids, phenyl-alcohols, phenyl-acids, hydroxyisochromans,
ﬂavonoids, and lignans
Among secondary metabolites, phenolic compounds are the most
widely distributed in plants, with more than 8000 phenolic structures
known. Phenolic compounds are ubiquitous in all plant organs and are
involved in the defense against UV radiation, extreme thermal condi-
tions, and aggression by pathogens or predators, tolerance to water
shortage, allelopathy, soil microbial activity, organic matter decomposi-
tion, andmineralization. Phenolic compounds possess one or more aro-
matic rings with one or more hydroxyl groups.
The phenolic fraction in virgin olive oil (and olive leaf) contains at
least 36 structurally different phenolic compounds, which can be divid-
ed into 6 major groups based on similarities in structure: secoiridoids,
phenyl-alcohols, phenyl-acids, hydroxyisochromans, ﬂavonoids, and
lignans [212–215]. Different factors have an inﬂuence on the variability
and concentration of phenolic compounds in virgin olive oil, whichmay
exceed 1500 mg/kg, including the cultivar (variety and age) and region
of olive tree growth, olive fruit maturation, and virgin olive oilprocessing [216,217]. The secoiridoids are typical in the botanical
family of Oleaceae, which includes O. europaea L (olive tree) and
may account for more than 80–90% of the total phenolic compounds
in virgin olive oil. The most abundant secoiridoids in virgin olive oil
are the dialdehyde form of decarboxymethyl elenolic acid linked to
hydroxytyrosol, the dialdehyde form of decarboxymethyl elenolic
acid linked to tyrosol, oleuropein aglycone (elenolic acid linked to
hydroxytyrosol), ligustroside aglycone (elenolic acid linked to
tyrosol), and hydroxytyrosol acetate (up to 600, 400, 300, 50, and
15 mg/kg, respectively). The predominant phenyl-alcohols in virgin
olive oil are hydroxytyrosol (3,4-dihydroxyphenylethanol) and
tyrosol (4-hydroxyphenylethanol) (up to 200 and 180 mg/kg, re-
spectively). Hydroxycinnamic structures (which contain 9 carbon
atoms, C6–C3) and hydrobenzoic structures (which contain 7 carbon
atoms, C6–C1) comprise the phenyl-acids found in virgin olive oil,
which include p-coumaric, o-coumaric, caffeic, ferulic, sinapic, gallic,
gentisic, syringic, vanillic, protocathechuic, and p-hydroxybenzoic
acids (up to 4 mg/kg per analyte). Two hydroxyisochromans formed
by the reaction of hydroxytyrosol with benzaldehyde (1-phenyl-
6,7-dihydroxyisochroman) or vanillin [1-(3-methoxy-4-hydroxy-
phenyl)-6,7-dihydroxyisochroman] have also been identiﬁed in vir-
gin olive oil (up to 0.4 and 1.5 mg/kg, respectively). The structure of
ﬂavonoids is based on a ﬂavan nucleus consisting of 3 phenolic rings
referred to as the A, B, and C rings. Variations in the heterocyclic C
ring give rise to the main groups of ﬂavonoids: ﬂavones, ﬂavanols,
ﬂavonols, ﬂavanones, isoﬂavones, and anthocyanins. The major ﬂa-
vonoids in virgin olive oil are the ﬂavones luteolin and apigenin
(up to 10 and 3 mg/kg, respectively) and the ﬂavonol quercetin
(up to 1 mg/kg). (+)-Pinoresinol, 1-(+)-acetoxypinoresinol, and
1-(+)-hydroxypinoresinol are the most common lignans in virgin
olive oil (up to 180, 80, and 20 mg/kg, respectively). The phenolic frac-
tion plays a signiﬁcant role in the sensory properties (bitterness, pun-
gency, and astringency) of virgin olive oil and in the protection and
stability of virgin olive oil against oxidation. Secoiridoids may undergo
hydrolysis under gastric conditions, resulting in signiﬁcant increases
in the amounts of hydroxytyrosol and tyrosol [13,218] and, to a lesser
extent, oleuropein and oleuropein aglycone [219,220] entering the
small intestine. Secoiridoids exhibit an absorption efﬁciency of approx-
imately 55 to 66% and an excretion rate of only 5 to 16% of the total
amount ingested [221]. A wide range of different phenolic compounds
has been detected in multiple animal tissues, including brain tissue,
after a single ingestion of the phenolic compounds found in virgin
olive oil [222].
Studies of unilamellarmembranes have revealed that phenolic com-
pounds (the dialdehyde form of decarboxymethyl elenolic acid linked
to hydroxytyrosol, oleuropein aglycone, oleuropein, hydroxytyrosol,
and hydroxytyrosol acetate) remain at the lipid membrane surface
area, almost parallel to the bilayer, which they do not penetrate
[223]. This is most likely due to the hydrophilic properties and the con-
formational mobility of phenolic non-planar structures, in contrast to
hydroxyisochromans with planar and lipophilic phenyl substituents,
which favors the deeper membrane localization of the phenolic mole-
cule [224]. In phospholipid/water systems, oleuropein exhibits a high
afﬁnity for phospholipid acyl chains, promoting no major changes in
the gel-to-Lα phase transition and a tendency to form inverted HII
phase structures in zwitterionic phospholipid-containing membranes
but inducing dramatic perturbations at the surface of membranes
formed with negatively charged phospholipids [225]. Similar mem-
brane localization and interaction, with most of the molecule exposed
to the aqueous phase, have been reported for ﬂavonoids, including
luteolin [226] and quercetin [227]. Incorporation of phenolic com-
pounds into themembranemay induce a deformation of themembrane
surface toward a negative membrane curvature. Therefore, the accom-
modation of lipidmembrane dynamics by phenolic compounds dictates
the ability of phenolic compounds to delay lipid peroxidation by trap-
ping peroxyl radicals from the aqueous phase and to prevent the
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membrane. This response may be heightened by cross-talk with hydro-
philic, amphipathic, and/or hydrophobic natural antioxidants, including
other phenolic compounds. The combination of phenolic compounds
with ascorbate or α-tocopherol has an additive or synergistic effect
against oxidative stress on membranes [223]. Phenolic compounds also
contribute to the regeneration and conservation of α-tocopherol mole-
cules [228,229]. Oleuropein aglycone, oleuropein, and/or hydroxytyrosol
confer antioxidant protection against oxidative injury in membranous
systems, including human red blood cells [230], liver cells [231], and
retinal pigment epithelial cells [232]. The antioxidant mechanisms of
phenolic compounds include reduction of oxygen concentration, termi-
nation of free radicals, decomposition of primary products of oxidation
to non-radical species, and prevention of continuous hydrogen abstrac-
tion from substrates and chelators of metal ions [233]. Independent of
redox-sensitive processes, phenolic compoundsmay exert additional bi-
ological activities at the membrane level. For example, oleuropein may
entropically interfere with the in vitro aggregation of islet amyloid poly-
peptide (amylin) in the membrane of human pancreatic β-cells, thereby
avoiding the toxic effects of amylin aggregates, which often involve
nonspeciﬁc membrane permeabilization and destruction of pancreatic
β-cells [234,235]. The pore-forming effect of α-synuclein oligomers on
synthetic membrane vesicles can be similarly prevented by apigenin,
which contains a critical dihydroxyphenyl ring structure, alone or as
part of the ﬂavone scaffold [236]. In vivo, oleuropein also plays a role in
blocking the membrane stressor activity of amyloid-β peptide aggre-
gates in an invertebrate model of AD and musculoskeletal degenerative
diseases such as inclusion bodymyositis [237]. Studies of the interaction
of phenolic compounds with integral membrane proteins indicate that
hydroxytyrosol may accelerate the oscillation of the norepinephrine
transporter between the outward-facing mode (accessible to the extra-
cellular medium) and the inward-facing mode (open to the intracellular
milieu) in an in vitromodel of differentiated sympathetic neurons [238].
Prospective epidemiological studies, some randomized prevention tri-
als, and many short-term studies of intermediate endpoints suggest that
the intake of virgin olive oil phenolic compounds—in combination with
oleic acid—may protect against cardiovascular diseases [3,14,239–243]
and different types of cancer [13,216,240,241,244,245] via synergistic
and overlapping protective antioxidant and anti-inﬂammatory effects as
well as other effects yet to be identiﬁed. The plasma incorporation of
phenolic compounds following virgin olive oil intake has been shown to
improve antioxidant status in elderly people [246] and endothelial dys-
function in patients with early atherosclerosis [247]. In vitro, phenolic
compounds can regulate genes involved in nitric oxide metabolism, pro-
teolysis of connective tissues, differentiation coupled to membrane-
bound oxidases, and nuclear factor-κB (NF-κB) signaling [248,249]. The
cooperation of hydroxytyrosol+ tyrosol or p-coumaric+ caffeic acid di-
minishes homocysteine-induced endothelial dysfunction by inhibiting
adhesion molecules in a redox-independent manner [250], whereas the
cooperation of hydroxytyrosol+ caffeic acidprotectsDNA fromoxidative
damage while exerting an antiproliferative effect on tumor cells [251].
Similar cellular effects, including reduced reactive oxygen species (ROS)
and reduced proliferation, have been reported for caffeic, syringic, and
protocathechuic acids [252]. Recent evidence also suggests that luteolin
inhibits human prostate tumor growth by suppressing vascular endothe-
lial growth factor 2-mediated angiogenesis [253] and apoptosis [254].
Other in vitro anticancer effects of luteolin include irreversible changes
in mitochondrial membrane structure/function [255] and the reversal of
the epithelial–mesenchymal transition [134], which may act in concert
with the ability of luteolin to enhance the activity of antitumor drugs
[256]. In addition, ferulic acid potentiates the radiosensitivity of human
cervical carcinoma cells [257]. Secoiridoids, ﬂavonoids, and lignans
strongly inhibit the overexpression of fatty acid synthase [258] and
the proto-oncogene HER2 (human epidermal growth factor receptor
2) [259] in tumor cells. Hydroxytyrosol, tyrosol, caffeic acid, and
(+)-pinoresinol exert anticancer effects by inhibiting invasion [260]and selectively activating the ataxia telangiectasiamutated-p53 cascade
[261]. Additional novel health effects andmechanisms of phenolic com-
pounds found in virgin olive oil are rapidly being identiﬁed. In vitro,
hydroxytyrosol, tyrosol, 1-(+)-acetoxypinoresinol, oleuropein agly-
cones, and notably, the dialdehyde form of decarboxymethyl elenolic
acid linked to tyrosol have strong activity against Helicobacter pylori
[262]. These results are in agreement with the observation that the ad-
ministration of virgin olive oil rich in phenolic compounds is moderate-
ly effective in eradicating H. pylori in patients with H. pylori-positive
status [263]. This suggests a potential role for these phenolic com-
pounds as chemo-preventative agents for peptic or gastric ulcers.
Oleuropein operates at a dose one order of magnitude lower than ranit-
idine in experimental injury of the gastric mucosa, improving the total
antioxidant capacity and cellmembrane integrity [264]. Hydroxytyrosol
has antifungal activity [265], and luteolin exerts antibacterial and syner-
gistic activity by altering outer and inner membrane permeability
in amoxicillin-resistant Escherichia coli [266]. Oleuropein has lipid-
lowering effects and confers protection against SFA (palmitic acid)-
induced hepatocellular steatosis [267]. The supplementation of diets
with hydroxytyrosol improves the inﬂammatory response in experi-
mental models of chronic colonic inﬂammation with clinical and
histological similarity to human ulcerative colitis [268]. Tyrosol has a
protective effect against mitochondrial dysfunction-induced dopami-
nergic neuronal death via activation of the phosphoinositide 3-kinase
(PI3K)/PKB signaling pathway, along with up-regulation of antioxidant
enzymes in an in vitromodel of AD [269]. Inmitochondria isolated from
the hippocampus, cortex, and striatum of transgenic mice doubly ex-
pressing amyloid-β precursor protein and presenilin 1, luteolin nearly
completely restores mitochondrial function by a mechanism associated
with ROS scavenging and/or stabilization of the electron transport chain
[270]. Luteolin also confers protection against ER stress-induced neuro-
nal cell death in the hippocampus in an experimental corticosterone-
treated depressionmodel [271]. Phenolic acids andﬂavonoids are active
in the prevention or delay of cataract development [272]. Luteolin in-
hibits NF-κB binding activity and the activator-protein-1 pathway as
well as their downstream target genes in gestational tissues, reducing
the secretion of pro-inﬂammatory cytokines, prostaglandins, and
metalloproteinases in fetal membranes, amnion, and myometrial cells
exposed to pro-inﬂammatory stress [273], indicating a potential thera-
peutic use of luteolin in pre-term birth. The plethora of beneﬁcial effects
associated with the phenolic compounds described above supports the
potential of virgin olive oil in treatingmetabolic syndrome, aswell as in-
fectious, neurodegenerative, and autoimmune diseases, all of which are
reaching pandemic levels and increasingly affecting human life. In 2011,
following a request from the European Commission, the Panel on
Dietetic Products, Nutrition and Allergies of the European Food Safety
Authority concluded that a cause and effect relationship had been
established between the consumption of virgin olive oil polyphenols
(standardized by the content of hydroxytyrosol and its derivatives)
and the protection of LDL particles from oxidative damage [274].
There is the hope that new health claims related to virgin olive oil con-
sumption will be recognized in the near future.
4.6. Tocopherols and tocotrienols
Essential in the human diet, vitamin E is a general term that is used
to describe a family of 8 different, naturally occurring forms: 4 tocoph-
erols (α-, β-, γ-, and δ-tocopherols) and 4 tocotrienols (α-, β-, γ-, and
δ-tocotrienols). A chromanol ring bearing a phenolic group and a lipo-
philic side chain are the functional domains of vitamin E [275,276].
The number of methyl groups attached at the 5-carbon atom and/or
7-carbon atom on the chromanol ring, in addition to a common methyl
group at the 8-carbon atom, designates each form. The α form is the
most highly methylated, with a maximum of 3 methyl groups on the
chromanol ring, comparedwith theβ andγ forms,which have 2methyl
groups (the common methyl group and one at the 5-carbon atom or
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commonmethyl group on the chromanol ring. Structurally, tocopherols
and tocotrienols differ in the branched side chain at the 2-carbon atom,
which is a saturated isoprenoid C16 side chain in tocopherols and a
farnesyl isoprenoid side chain with trans double bonds at the 3′-, 7′-,
and 11′-carbon atoms in tocotrienols. α-Tocopherol is the most biolog-
ically active form of vitamin E and accounts for nearly 95% of the total
vitamin E found in virgin olive oil (up to 300 mg/kg). The concentra-
tions of the different forms of vitamin E in virgin olive oil are approxi-
mately 300 mg/kg α-tocopherol, 3 mg/kg α-tocotrienol, 4 mg/kg
β-tocopherol, 1 mg/kg β-tocotrienol, 2 mg/kg δ-tocopherol, 12 mg/kg
γ-tocopherol, and 5 mg/kg γ-tocotrienol. Different factors inﬂuence
the variability and concentration of tocopherols in virgin olive oil, in-
cluding the cultivar (variety and age) and region of olive tree growth,
olive fruit maturation, harvesting and processing conditions, and virgin
olive oil storage conditions [277–284]. These natural antioxidants not
only provide nutritional value to virgin olive oil but also contribute to
its stabilitywith respect to oxidation, even during heating at frying tem-
perature, thereby preserving its quality.
Among the members of the vitamin E family of compounds,
α-tocopherol is selectively enriched in the plasma and tissues via inde-
pendent activities of a hepatic α-tocopherol transfer protein that
retainsα-tocopherol, as well as the catabolizing cytochrome P-450 sys-
tem, which preferentially degrades all other forms of vitamin E [285].
The lipophilic side chain enables the anchoring and penetration of to-
copherols and tocotrienols into biological membranes, where they
function as chain-terminating hydrogen atom donors to lipid peroxy
radicals [286–289]. Tocopherols and tocotrienols are inserted into one
leaﬂet of the lipid bilayer, parallel to membrane phospholipid chains
with the active hydroxyl group at the lipid–water interface, and exert
mainly the same mobility [290]. They show preferential afﬁnity for
and co-localize with PUFAs and partition into non-raft domains rich in
PUFAs [288]. This orientation and localization inﬂuence membrane54
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Fig. 5. Schematic representation illustrating the estimated positions of oleic acid and various m
yellow. The chemical structures were obtained from the 3D Conformer utility in the PubChemconformational dynamics; in some cases, tocopherols modulate the
structure of unsaturated phospholipid bilayers in a similar manner as
cholesterol in lipid rafts [291]. At membrane tocopherol concentrations
above 10 mol%, themain transition temperature decreases continuously
in a concentration-dependent manner, except for α- and δ-tocopherols,
which stabilize a modulated Pβ phase (in between the gel-to-Lα phase
transition). γ-Tocopherol ﬂuidizes the bilayer more efﬁciently than
α- and δ-tocopherols but not as efﬁciently as cholesterol. At a narrow
composition range between 7.5 and 10mol% and coupled to the bilayer
curvature, tocopherols favor the asymmetric ripple Pβ′ phase, which is
characterized by corrugations of the membrane surface with well-
deﬁned periodicity and a bilayer thickness that is different in the 2
arms of the ripple and increases with increasing tocopherol concentra-
tion in the membrane. By contrast, tocotrienols are more readily trans-
ferred tomembranes and causemoreminor ordering disturbances than
tocopherols. This intricate arrangement of tocopherols and tocotrienols
in membranes optimizes protection against peroxy-radicals created
within PUFA chains as well as the regeneration of tocopheroxyl/
tocotrienoxyl radicals by water-soluble reducing agents such as ascor-
bate and phenolic compounds; such arrangement has membrane-
stabilizing and reparative effects [292].
Evidence suggests that corresponding tocopherols and tocotrienols
display similar potency for radical scavenging in homogenous solution
systems and liposomal membranes [293,294]. The hydrophobic prenyl
chain in the different vitamin E forms appears not to signiﬁcantly affect
hydrogen donor propensities, which increase with increasing methyla-
tion degree of the chromanol ring (α N β= γ N δ). Thus, a high plasma
concentration of vitamin E, implying a high total plasma antioxidant ca-
pacity, has been associatedwith lower risks of cardiovascular disease and
some types of cancer [275,295,296]. Vitamin E has also been shown to
play a critical role in central nervous system health. The therapeutic
beneﬁt of vitamin E is related to the prevention andmanagement of neu-
rodegenerative disorders such as AD and Parkinson's disease [297,298].6
8
7
1
5
6
7
8
Erythrodiol
Hydroxytyrosol
Luteolin
α-Tocopherol 
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Structure database (http://pubchem.ncbi.nlm.nih.gov/search/search.cgi#).
1651S. Lopez et al. / Biochimica et Biophysica Acta 1838 (2014) 1638–1656Moreover, increasing evidence suggests novel mechanisms of action for
vitamin E independent of antioxidant activity and a different spectrum
of biological activities for tocopherols and tocotrienols [299,300].
5. Conclusions and future directions
The role of evolution in creating lipid bilayers to allow for the inter-
action of cells with the environment is interesting. This review provides
compelling evidence regarding how oleic acid and the minor constitu-
ents of virgin olive oil interact with and regulate the functions of mem-
branes. Oleic acid can be efﬁciently incorporated into phospholipids,
forming the core of the lipid bilayer and regulating the activity of inte-
gral or peripheral membrane proteins. Minor constituents exhibit a
wide range of lipophilicity, which causes preferential localization of
these constituents within the membrane or on the bilayer/water inter-
face (Fig. 5). Despite the low concentrations of someminor constituents
of virgin olive oil, their spatial conﬁnement in themembranemay great-
ly enhance their local concentration, synergy, and co-localization in
relevant regions or microdomains. However, further work needs to be
done to conﬁdently establish that oleic acid and the minor constituents
of virgin olive oil are absorbed, metabolized, and directed to target
membranes while retaining their therapeutic beneﬁts, as well as to
gain mechanistic insights into the multilateral and cooperative actions
of these bioactive entities in membrane lipid and protein dynamics in
health and disease.
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